Trial
NCT06623240
HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Hope Biosciences Research Foundation
Collaborators
—
Condition
Juvenile Idiopathic Arthritis (JIA)
Intervention
allogeneic Hope Biosciences adipose-derived mesenchymal stem cells
Why stopped
In the time that the site has been active, there have been 0 patients enrolled despite our best efforts. It is clear that it is not feasible to conduct this study at this time; therefore, we have withdrawn this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-07